Chris Behrenbruch

Melbourne

Chris Behrenbruch in Melbourne works at Telix Pharmaceuticals Limited (CEO and Managing Director) and was educated at University of Oxford.

  Share this profile

Telix Pharmaceuticals Limited Dec 2015 - Present
CEO and Managing Director

Amplia Therapeutics May 2016 - Feb 2020
Co-Founder and Director

Monash University Apr 2013 - Jun 2018
Adjunct Professor

University of Oxford   1998 - 2001
Ph.D (D.Phil)

University of Melbourne   2010 - 2015
Juris Doctor (Law)